Carbamazepine and diclofenac: Removal in wastewater treatment plants and occurrence in water bodies
Tóm tắt
Từ khóa
Tài liệu tham khảo
Alder, 2006, Consumption and Occurrence
Andreozzi, 2002, Carbamazepine in water: persistence in the environment ozonation treatment and preliminary assessment on algal toxicity, Water Res., 36, 2869, 10.1016/S0043-1354(01)00500-0
Andreozzi, 2003, Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment, Chemosphere, 50, 1319, 10.1016/S0045-6535(02)00769-5
Ashton, 2004, Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom, Sci. Total Environ., 333, 167, 10.1016/j.scitotenv.2004.04.062
Benotti, 2007, Distributions of pharmaceuticals in an urban estuary during both dry- and wet-weather conditions, Environ. Sci. Technol., 41, 5795, 10.1021/es0629965
Bernus, 1994, Early stage autoinduction of carbamazepine metabolism in humans, Eur. J. Clin. Pharmacol., 47, 355, 10.1007/BF00191168
Bernus, 1995, Metabolism of carbamazepine and co-administered anticonvulsants during pregnancy, Epilepsy Res., 21, 65, 10.1016/0920-1211(95)00012-Y
BLAC, 2003. Arzneimittel in der Umwelt Auswertung der Untersuchungsergebnisse. <http://www.blak-uis.de/servlet/is/2146/P-2c.pdf>.
Bound, 2005, Household disposal of pharmaceuticals as a pathway for aquatic contamination in the United Kingdom, Environ. Health Perspect., 113, 1705, 10.1289/ehp.8315
Brunner, 2005, Favourable dermal penetration of diclofenac after administration to the skin using a novel spray gel formulation, Br. J. Clin. Pharmacol., 60, 573, 10.1111/j.1365-2125.2005.02484.x
Buser, 1998, Occurrence and fate of the pharmaceutical drug diclofenac in surface waters: rapid photodegradation in a lake, Environ. Sci. Technol., 33, 3449, 10.1021/es980301x
Castiglioni, 2006, Removal of pharmaceuticals in sewage treatment plants in Italy, Environ. Sci. Technol., 40, 357, 10.1021/es050991m
Clara, 2004, Comparison of the behaviour of selected micropollutants in a membrane bioreactor and a conventional wastewater treatment plant, Water Sci. Technol., 50, 29, 10.2166/wst.2004.0305
Clara, 2004, Carbamazepine as a possible anthropogenic marker in the aquatic environment: investigations on the behaviour of carbamazepine in wastewater treatment and during groundwater infiltration, Water Res., 38, 947, 10.1016/j.watres.2003.10.058
Clara, 2005, The solids retention time – a suitable design parameter to evaluate the capacity of wastewater treatment plants to remove micropollutants, Water Res., 39, 97, 10.1016/j.watres.2004.08.036
Clara, 2005, Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants, Water Res., 39, 4797, 10.1016/j.watres.2005.09.015
Cleuvers, 2004, Mixture toxicity of the anti-inflammatory drugs diclofenac, ibuprofen, naproxen, and acetylsalicylic acid, Ecotox. Environ. Safe., 59, 309, 10.1016/S0147-6513(03)00141-6
Cohen, 2005, TRIPS the Doha declaration and increasing access to medicines: policy options for Ghana, Global. Health, 1, 1, 10.1186/1744-8603-1-17
Daughton, 1999, Pharmaceuticals and personal care products in the environment: agents of subtle change?, Environ. Health Perspect., 107, 907, 10.1289/ehp.99107s6907
Deng, 2003, Residue analysis of the pharmaceutical diclofenac in different water types using ELISA and GC–MS, Environ. Sci. Technol., 37, 3422, 10.1021/es0341945
Dietrich, 1999, Fish embryotoxicity and teratogenicity of pharmaceuticals, detergents and pesticides regularly detected in sewage treatment plant effluents and surface waters, Toxicologist, 48, 151
Drewes, 2002, Fate of pharmaceuticals during indirect potable reus, Water Sci. Technol., 46, 73, 10.2166/wst.2002.0058
Encinas, 1998, Phototoxicity associated with diclofenac: a photophysical, photochemical, and photobiological study on the drug and its photoproducts, Chem. Res. Toxicol., 11, 946, 10.1021/tx9800708
EUROPA, 2006. Key facts and figures about Europe and the Europeans. <http://europa.eu/abc/keyfigures/index_en.htm>.
Ferrari, 2003, Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac, Ecotox. Environ. Safe., 55, 359, 10.1016/S0147-6513(02)00082-9
Fitzke, B., Geißen, S.U., Vogelpohl, A., 2003. Pharmaceutical pollution in hospital wastewater – new applications for AOP’s. In: Vogelpohl, A. (Ed.). Proceedings of Third International Conference on Oxidation Technologies for Water and Wastewater Treatment, Goslar, pp. 369–373.
Green, 2004, Diclofenac poisoning as a cause of vulture population declines across the Indian subcontinent, J. Appl. Ecol., 41, 793, 10.1111/j.0021-8901.2004.00954.x
Halling-Sørensen, 1998, Occurrence, fate and effects of pharmaceutical substances in the environment – a review, Chemosphere, 32, 357, 10.1016/S0045-6535(97)00354-8
Heberer, 2002, Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data, Toxicol. Lett., 131, 5, 10.1016/S0378-4274(02)00041-3
Heberer, 2002, Tracking persistent pharmaceutical residues from municipal sewage to drinking water, J. Hydrol., 266, 175, 10.1016/S0022-1694(02)00165-8
Heberer, 2005, Contribution of effluents from hospitals and private households to the total loads of diclofenac and carbamazepine in municipal sewage effluents–modeling versus measurements, J. Hazard. Mater., 122, 211, 10.1016/j.jhazmat.2005.03.007
Heberer, 1998, Occurrence and distribution of organic contaminants in the aquatic system in Berlin. Part I: Drug residues and other polar contaminants in Berlin surface and groundwater, Acta Hydrochim. Hydrobiol., 26, 272, 10.1002/(SICI)1521-401X(199809)26:5<272::AID-AHEH272>3.0.CO;2-O
Heberer, 2001, Occurrence and fate of pharmaceuticals during bank filtration – preliminary results from investigations in Germany and the United States, Water Resour. Update, 120, 4
Heberer, 2002, From municipal sewage to drinking water: fate and removal of pharmaceutical residues in the aquatic environment in urban areas, Water Sci. Technol., 46, 81, 10.2166/wst.2002.0060
Hoover, 2005, Carbamazepine
Hua, 2006, Ozone treatment and the depletion of detectable pharmaceuticals and atrazine herbicide in drinking water sourced from the upper Detroit River, Ontario, Canada, Water Res., 40, 2259, 10.1016/j.watres.2006.04.033
Huber, 2005, Oxidation of pharmaceuticals during ozonation of municipal wastewater effluents: a pilot study, Environ. Sci. Technol., 39, 4290, 10.1021/es048396s
Jones, 2002, Aquatic environmental assessment of the top 25 English prescription pharmaceuticals, Water Res., 36, 5013, 10.1016/S0043-1354(02)00227-0
Jos, 2003, Ecotoxicological evaluation of carbamazepine using six different model systems with eighteen endpoints, Toxicol. In Vitro, 17, 525, 10.1016/S0887-2333(03)00119-X
Joss, 2005, Removal of pharmaceuticals and fragrances in biological wastewater treatment, Water Res., 39, 3139, 10.1016/j.watres.2005.05.031
Joss, 2006, Biological degradation of pharmaceuticals in municipal wastewater treatment: proposing a classification scheme, Water Res., 40, 1686, 10.1016/j.watres.2006.02.014
Khan, 2004, Modelling of pharmaceutical residues in Australian sewage by quantities of use and fugacity calculations, Chemosphere, 54, 355, 10.1016/j.chemosphere.2003.07.001
Kim, 2007, Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters, Water Res., 41, 1013, 10.1016/j.watres.2006.06.034
Kimura, 2007, Elimination of selected acidic pharmaceuticals from municipal wastewater by an activated sludge system and membrane bioreactors, Environ. Sci. Technol., 41, 3708, 10.1021/es061684z
Kolpin, 2002, Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. Streams, 1999–2000: a national reconnaissance, Environ. Sci. Technol., 36, 1202, 10.1021/es011055j
Koutsouba, 2003, Determination of polar pharmaceuticals in sewage water of Greece by gas chromatography–mass spectrometry, Chemosphere, 51, 69, 10.1016/S0045-6535(02)00819-6
Kreuzinger, 2004, Relevance of the sludge retention time (SRT) as design criteria for wastewater treatment plants for the removal of endocrine disruptors and pharmaceuticals from wastewater, Water Sci. Technol., 50, 149, 10.2166/wst.2004.0322
Kümmerer, 2001, Drugs in the environment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources – a review, Chemosphere, 45, 957, 10.1016/S0045-6535(01)00144-8
Laville, 2004, Effects of human pharmaceuticals on cytotoxicity, EROD activity and ROS production in fish hepatocytes, Toxicology, 196, 41, 10.1016/j.tox.2003.11.002
Lee, 2003, Acidic pharmaceuticals in sewage-methodology, stability test, occurrence, and removal from Ontario samples, Water Qual. Res. J. Can., 38, 667, 10.2166/wqrj.2003.042
Lindqvist, 2005, Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving waters, Water Res., 39, 2228, 10.1016/j.watres.2005.04.003
Lishman, 2006, Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada, Sci. Total Environ., 367, 544, 10.1016/j.scitotenv.2006.03.021
Löffler, 2005, Environmental fate of pharmaceuticals in water/sediment systems, Environ. Sci. Technol., 39, 5209, 10.1021/es0484146
Mersmann, 2002, Säulenversuche zum Transportverhalten von Arzneimittelwirkstoffen in der wassergesättigten Zone (Column experiments on the transport behavior of pharmaceutically active compounds in the saturated zone), Acta Hydrochim. Hydrobiol., 30, 275, 10.1002/aheh.200390009
Miao, 2003, Determination of carbamazepine and its metabolites in aqueous samples using liquid chromatography–electrospray tandem mass spectrometry, Anal. Chem., 75, 3731, 10.1021/ac030082k
Miao, 2005, Carbamazepine and its metabolites in wastewater and in biosolids in a municipal wastewater treatment plant, Environ. Sci. Technol., 39, 7469, 10.1021/es050261e
Moser, 2007, Microverunreinigungen – Vorbehandlung von Spitalabwasser, Gwa, 11, 869
Mückter, 2008
Nakada, 2006, Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment, Water Res., 40, 3297, 10.1016/j.watres.2006.06.039
Nakada, 2007, Occurrence of 70 pharmaceutical and personal care products in Tone River basin in Japan, Water Sci. Technol., 56, 133, 10.2166/wst.2007.801
Oaks, 2004, Diclofenac residues as the cause of vulture population decline in Pakistan, Nature, 427, 630, 10.1038/nature02317
Osenbrück, 2007, Sources and transport of selected organic micropollutants in urban groundwater underlying the city of Halle (Saale), Germany, Water Res., 41, 3259, 10.1016/j.watres.2007.05.014
Packer, 2003, Photochemical fate of pharmaceuticals in the environment: naproxen, diclofenac, clofibric acid, and ibuprofen, Aquat. Sci., 65, 342, 10.1007/s00027-003-0671-8
Palmer, 2008, Sources of pharmaceutical pollution in the New York City Watershed, Sci. Total Environ., 394, 90, 10.1016/j.scitotenv.2008.01.011
Pauwels, 2006, Effluent quality of a conventional activated sludge and a membrane bioreactor system treating hospital wastewater, Environ. Technol., 27, 395, 10.1080/09593332708618651
Paxéus, 2004, Removal of selected non-steroidal anti-inflammatory drugs (NSAIDs), gemfibrozil, carbamazepine, β-blockers, trimethoprim and triclosan in conventional wastewater treatment plants in five EU countries and their discharge to the aquatic environment, Water Sci. Technol., 50, 253, 10.2166/wst.2004.0335
Pérez-Estrada, 2005, Photo-Fenton degradation of diclofenac: identification of main intermediates and degradation pathway, Environ. Sci. Technol., 39, 8300, 10.1021/es050794n
Poiger, 2001, Photodegradation of the pharmaceutical drug diclofenac in a lake: pathway, field measurements, and mathematical modeling, Environ. Toxicol. Chem., 20, 256, 10.1002/etc.5620200205
POSEIDON, 2006. POSEIDON Final Report: Assessment of Technologies for the Removal of Pharmaceuticals and Personal Care Products in Sewage and Drinking Water Facilities to Improve the Indirect Potable Water Reuse. Contract No. EVK1-CT-2000-00047.
Quintana, 2005, Pathways and metabolites of microbial degradation of selected acidic pharmaceutical and their occurrence in municipal wastewater treated by a membrane bioreactor, Water Res., 39, 2654, 10.1016/j.watres.2005.04.068
Rabiet, 2006, Consequences of treated water recycling as regards pharmaceuticals and drugs in surface and ground waters of a medium-sized mediterranean catchment, Environ. Sci. Technol., 40, 5282, 10.1021/es060528p
Reith, 2000, The effect of body size on the metabolic clearance of carbamazepine, Biopharm. Drug Dispos., 21, 103, 10.1002/1099-081X(200004)21:3<103::AID-BDD222>3.0.CO;2-8
RxList, 2006. The Internet Drug Index. <http://www.rxlist.com>.
Santos, 2007, Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain), Environ. Int., 33, 596, 10.1016/j.envint.2006.09.014
Sawchuk, 1995, Analysis of diclofenac and four of its metabolites in human urine by HPLC, Pharm. Res., 12, 756, 10.1023/A:1016276012891
Scheytt, 2004, Transport of pharmaceutically active compounds in saturated laboratory columns, Ground Water, 42, 767, 10.1111/j.1745-6584.2004.tb02730.x
Scheytt, 2006, Mobility of pharmaceuticals carbamazepine, diclofenac, ibuprofen, and propyphenazone in miscible-displacement experiments, J. Contam. Hydrol., 83, 53, 10.1016/j.jconhyd.2005.11.002
Schneider, 1981, Simultaneous determination of diclofenac sodium and its hydroxy metabolites by capillary column gas chromatography with electron-capture detection, J. Chromatogr., 217, 263, 10.1016/S0021-9673(00)88081-4
Schwaiger, 2004, Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part I: Histopathological alterations and bioaccumulation in rainbow trout, Aquat. Toxicol., 68, 141, 10.1016/j.aquatox.2004.03.014
Shultz, 2004, Diclofenac poisoning is widespread in declining vulture populations across the Indian subcontinen, Proc. Roy. Soc. London B, 271, S458, 10.1098/rsbl.2004.0223
Skadsen, J.M., Rice, B.L., Meyering, D.J., 2004. The Occurrence and Fate of Pharmaceuticals, Personal Care Products and Endocrine Disrupting Compounds in a Municipal Water Use Cycle: A Case Study in the City of Ann Arbor. City of Ann Arbor, Water Utilities and Fleis & VandenBrink Engineering, Inc. <www.a2gov.org>.
Sosiak, A., Hebben, T., 2005. A preliminary survey of pharmaceuticals and endocrine disrupting compounds in treated municipal wastewaters and receiving rivers of alberta. Alberta Environ. <http://www3.gov.ab.ca/env/info/infocentre/publist.cfm>.
Soulet, 2002, Analysis of acidic drugs in Swiss wastewaters, Int. J. Environ. Anal. Chem., 82, 659, 10.1080/0306731021000075384
Spongberg, 2008, Pharmaceutical compounds in the wastewater process stream in northwest Ohio, Sc. Total Environ., 397, 148, 10.1016/j.scitotenv.2008.02.042
SRC, 2006. PhysProp Database. <http://www.syrres.com/esc/physdemo.htm>.
Stamatelatou, 2003, Pharmaceuticals and health care products in wastewater effluents: the example of carbamazepine, Water Sci. Technol: Water Supply, 3, 131
Stan, 1994, Occurrence of clofibric acid in the aquatic system – is the use in human medical care the source of the contamination of surface ground and drinking water?, Vom Wasser, 83, 57
Strenn, 2004, Carbamazepine, diclofenac, ibuprofen and bezafibrate – investigations on the behaviour of selected pharmaceuticals during wastewater treatment, Water Sci. Technol., 50, 269, 10.2166/wst.2004.0337
Stumpf, 1999, Polar drug residues in sewage and natural waters in the State of Rio de Janeiro, Brazil, Sci. Total Environ., 225, 135, 10.1016/S0048-9697(98)00339-8
Suárez, 2005, Removal of pharmaceutically active compounds in nitrifying–denitrifying plants, Water Sci. Technol., 52, 9, 10.2166/wst.2005.0214
Ternes, 1998, Occurrence of drugs in German sewage treatment plants and rivers, Water Res., 32, 3245, 10.1016/S0043-1354(98)00099-2
Ternes, 2004, A rapid method to measure the solid–water distribution coefficient (Kd) for pharmaceuticals and musk fragrances in sewage sludge, Water Res., 38, 4075, 10.1016/j.watres.2004.07.015
Thacker, 2005, Pharmaceutical data eludes environmental researchers, Environ. Sci. Technol., 39, 193A
Theisohn, 1982, Disposition of the antiepileptic oxcarbazepine and its metabolites in healthy volunteers, Eur. J. Clin. Pharmacol., 22, 545, 10.1007/BF00609629
Thomas, 2004, The occurrence of selected human pharmaceutical compounds in UK estuaries, Mar. Pollut. Bull., 49, 436, 10.1016/j.marpolbul.2004.02.028
Tixier, 2003, Occurrence and fate of carbamazepine, clofibric acid, diclofenac, ibuprofen, ketoprofen, and naproxen in surface waters, Environ. Sci. Technol., 37, 1061, 10.1021/es025834r
Triebskorn, 2004, Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part II: Cytological effects in liver, kidney, gills and intestine of rainbow trout (Oncorhynchus mykiss), Aquat. Toxicol., 68, 151, 10.1016/j.aquatox.2004.03.015
UK-National-Statistics, 2001. Cencus 2001. <http://www.statistics.gov.uk/census2001/pyramids/pages/64.asp>.
UN, 2005. World Population Prospect: The 2004 Revision Population Database. <http://esa.un.org/unpp/>.
Urase, 2005, Separate estimation of adsorption and degradation of pharmaceutical substances and estrogens in the activated sludge process, Water Res., 39, 1289, 10.1016/j.watres.2005.01.015
van Stee, 2002, Use of semi-permeable membrane devices and solid-phase extraction for the wide-range screening of microcontaminants in surface water by GC–AED/MS, Water Res., 36, 4455, 10.1016/S0043-1354(02)00177-X
Vieno, 2005, Seasonal variation in the occurrence of pharmaceuticals in effluents from a sewage treatment plant and in the recipient water, Environ. Sci. Technol., 39, 8220, 10.1021/es051124k
Vieno, 2007, Elimination of pharmaceuticals in sewage treatment plants in Finland, Water Res., 41, 1001, 10.1016/j.watres.2006.12.017
Weigel, 2001, New method for rapid solid-phase extraction of large-volume water samples and its application to non-target screening of North Sea water for organic contaminants by gas chromatography–mass spectrometry, J. Chromatogr. A, 912, 151, 10.1016/S0021-9673(01)00529-5
Weigel, 2002, Drugs and personal care products as ubiquitous pollutants – occurrence and distribution of clofibric acid, caffeine and DEET in the North Sea, Sci. Total Environ., 295, 131, 10.1016/S0048-9697(02)00064-5
Weigel, 2004, Simultaneous solid-phase extraction of acidic, neutral and basic pharmaceuticals from aqueous samples at ambient (neutral) pH and their determination by gas chromatography–mass spectrometry, J. Chromatogr. A, 1023, 183, 10.1016/j.chroma.2003.10.036
Wen, 2004, Treatment of hospital wastewater using a submerged membrane bioreactor, Process Biochem., 39, 1427, 10.1016/S0032-9592(03)00277-2
Westerhoff, 2005, Fate of endocrine-disruptor, pharmaceutical, and personal care product chemicals during simulated drinking water treatment processes, Environ. Sci. Technol., 39, 6649, 10.1021/es0484799
Wishart, 2006, DrugBank: a comprehensive resource for in silico drug discovery and exploration, Nucleic Acids Res., 34, D668, 10.1093/nar/gkj067